Well stated Guts. Below is a somewhat redacted ve
Post# of 7769
Posted On: 01/12/2014 5:44:21 PM
Well stated Guts. Below is a somewhat redacted version of an email I sent to another friend from across the pond who plans to initiate a position tomorrow (maybe my email below is a little too optimistic, but not completely unrealistic).
I'm pleased you have decided to join me in Scrips. It would be great if your golf buddies joined you as well. You will be very happy you did. The more investors like us buying up the shares, the better we will all be -- more of the unofficial float would be in stronger hands. Counting my shares and the shares of my other friends and family who have joined me here, I believe we own 5,238,844 (20 investors, 4 of whom have not disclosed their share count). Adding your 200k-300K shares will take us over 5.5M shares. I know of many others who intend to add many more or who are waiting on the sidelines for more positive news before investing. I also speak frequently with a few other big investing groups comprised of retail investors like us -- counting everything, all of us likely own more than 20M of the float.
Though $.65 will be fantastic, I intend to hold between 70%-90% of my current position through early or mid-2015. I'll re-assess then. I'll probably hold the majority through 2015. In less than a year we will know much more about where this company is heading. Indeed, I expect the PPS to hit $5 if the company succeeds on all of the following longterm goals:
1. Builds best-in-breed mini-McKesson business for the more than 20K independent pharmacies and small retailers in the U.S., which will include at least 6 sales reps selling for WholesaleRX and PIMD, each entity with class 2 licenses (minimum with 6 reps is about $2M monthly by mid-2014, $24M minimum annual run rate, $36M if all sales reps are rock stars and average $500K monthly);
2. Acquires more drug supply chain businesses and/or a larger ownership interest in WholesaleRX, thus further increasing the bottom line (presently 20%)(remember, we own 90% of PIMD, which is likely where Scrips will be focusing its sales staff as they continue to ramp up this low-risk business model);
3. Secures strong foothold in China with Children's RapiMed, launches an improved RapiMed formula with IP protection and expands its sales to many more formulations of RapiMed drug and vitamin products (considering Children's RapiMed alone would generate about $27.5M annually with merely a quarter percent of the $11B Chinese pediatric OTC market in 2015, the potential for an expanded RapiMed brand maturing in the broader Chinese OTC, Rx and vitamin markets is immense);
4. Expands RapiMed brand to other large foreign markets (e.g., Europe, Latin America, Canada, South Africa, India)(with the revenues from RapiMed China, Scrips will have vast resources to fund RapiMed launches in the rest of Asia and other large foreign markets).
5. Successful RapiMed launch in the $1.4B U.S. pediatric OTC market with similar product improvements and expansions as the brand matures (of course, the same expansion opportunities of the RapiMed brand exists in the U.S. market); and
6. .,,
If Scrips hits a home run on just #1 and sold everything else off for $1, the PPS would exceed $.65 within a year and we would be celebrating over some very fine wine indeed!
Be well,
I'm pleased you have decided to join me in Scrips. It would be great if your golf buddies joined you as well. You will be very happy you did. The more investors like us buying up the shares, the better we will all be -- more of the unofficial float would be in stronger hands. Counting my shares and the shares of my other friends and family who have joined me here, I believe we own 5,238,844 (20 investors, 4 of whom have not disclosed their share count). Adding your 200k-300K shares will take us over 5.5M shares. I know of many others who intend to add many more or who are waiting on the sidelines for more positive news before investing. I also speak frequently with a few other big investing groups comprised of retail investors like us -- counting everything, all of us likely own more than 20M of the float.
Though $.65 will be fantastic, I intend to hold between 70%-90% of my current position through early or mid-2015. I'll re-assess then. I'll probably hold the majority through 2015. In less than a year we will know much more about where this company is heading. Indeed, I expect the PPS to hit $5 if the company succeeds on all of the following longterm goals:
1. Builds best-in-breed mini-McKesson business for the more than 20K independent pharmacies and small retailers in the U.S., which will include at least 6 sales reps selling for WholesaleRX and PIMD, each entity with class 2 licenses (minimum with 6 reps is about $2M monthly by mid-2014, $24M minimum annual run rate, $36M if all sales reps are rock stars and average $500K monthly);
2. Acquires more drug supply chain businesses and/or a larger ownership interest in WholesaleRX, thus further increasing the bottom line (presently 20%)(remember, we own 90% of PIMD, which is likely where Scrips will be focusing its sales staff as they continue to ramp up this low-risk business model);
3. Secures strong foothold in China with Children's RapiMed, launches an improved RapiMed formula with IP protection and expands its sales to many more formulations of RapiMed drug and vitamin products (considering Children's RapiMed alone would generate about $27.5M annually with merely a quarter percent of the $11B Chinese pediatric OTC market in 2015, the potential for an expanded RapiMed brand maturing in the broader Chinese OTC, Rx and vitamin markets is immense);
4. Expands RapiMed brand to other large foreign markets (e.g., Europe, Latin America, Canada, South Africa, India)(with the revenues from RapiMed China, Scrips will have vast resources to fund RapiMed launches in the rest of Asia and other large foreign markets).
5. Successful RapiMed launch in the $1.4B U.S. pediatric OTC market with similar product improvements and expansions as the brand matures (of course, the same expansion opportunities of the RapiMed brand exists in the U.S. market); and
6. .,,
If Scrips hits a home run on just #1 and sold everything else off for $1, the PPS would exceed $.65 within a year and we would be celebrating over some very fine wine indeed!
Be well,
(0)
(0)ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼